- Home
- CLDX
as of 12-19-2025 3:38pm EST
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | HAMPTON |
| Market Cap: | 1.9B | IPO Year: | 2008 |
| Target Price: | $44.10 | AVG Volume (30 days): | 718.4K |
| Analyst Decision: | Buy | Number of Analysts: | 10 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.38 | EPS Growth: | N/A |
| 52 Week Low/High: | $14.40 - $30.50 | Next Earning Date: | 11-10-2025 |
| Revenue: | $2,599,000 | Revenue Growth: | -73.95% |
| Revenue Growth (this year): | -62.18% | Revenue Growth (next year): | 19.70% |
AI-Powered CLDX Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Celldex Therapeutics Inc. (CLDX)
SVP & GENERAL COUNSEL
Avg Cost/Share
$29.10
Shares
4,166
Total Value
$121,209.77
Owned After
30,796
SEC Form 4
Other
Avg Cost/Share
$24.00
Shares
49,298
Total Value
$1,183,176.65
Owned After
20,833
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Jimenez Freddy A. | CLDX | SVP & GENERAL COUNSEL | Dec 4, 2025 | Sell | $29.10 | 4,166 | $121,209.77 | 30,796 | |
| Wright Richard M. | CLDX | Other | Nov 13, 2025 | Sell | $24.00 | 49,298 | $1,183,176.65 | 20,833 |
Compare CLDX vs Leading Stocks
See how CLDX stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "CLDX Celldex Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.